Investigating the complexity and functionality of CLN3 transcripts
Juvenile CLN3 disease, the most common form of the neuronal ceroid lipofuscinoses (NCLs), is mostly caused by an intragenic deletion which removes two coding exons in the CLN3 gene, yet the complexity of CLN3 transcripts and their contribution to ...
Zhang, Haoyu
core
Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease). [PDF]
Wang QJ, Jung KS, Mohan K, Kleinman ME.
europepmc +1 more source
Autophagic vacuolar myopathy is a common feature of CLN3 disease. [PDF]
Radke J +9 more
europepmc +1 more source
High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk. [PDF]
Malysheva V +34 more
europepmc +1 more source
Miglustat in Neuronopathic Lysosomal Storage Disorders: Biological Rationale, Clinical Evidence, and Limits of Repurposing. [PDF]
Lipiński P, Węgrzyn G.
europepmc +1 more source
Related searches:
CLN3, The Protein Associated With Batten Disease: Structure, Function and Localization
Journal of Neuroscience Research, 2005AbstractBatten disease, an inherited neurodegenerative storage disease affecting children, results from the autosomal recessive inheritance of mutations in Cln3. The function of the CLN3 protein remains unknown. A key to understanding the pathology of this devastating disease will be to elucidate the function of CLN3 at the cellular level.
David A Pearce +2 more
exaly +3 more sources
Combined Anti-Inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in Cln3−/− Mice [PDF]
Batten disease, or juvenile NCL, is a fatal neurodegenerative disorder that occurs due to mutations in the CLN3 gene. Because the function of CLN3 remains unclear, experimental therapies for JNCL have largely concentrated upon the targeting of downstream
Frances Platt, Ming J Lim, David Smith
exaly +4 more sources
Farnesylation of Batten Disease CLN3 Protein
Neuropediatrics, 1997The carboxyl terminal of the predicted amino acid sequence of the Batten disease CLN3 gene protein is CQLS. This motif is expected to be a site for farnesylation at the cysteine residue. In order to determine whether this is indeed farnesylated we have carried out the in-vitro prenylation of tetrapeptides CVLS, CAIL and CQLS using a farnesyl ...
R K, Pullarkat, G N, Morris
openaire +2 more sources

